Clover Health Investments, Corp.
CLOV
Rank in Stocks
#5109
Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare... Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare Advantage insurance. The company leverages its proprietary software platform, the Clover Assistant, to provide both Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) health plans for individuals eligible for Medicare. In addition to its insurance operations, Clover Health also engages in non-insurance-related business ventures. The company was established in 2014 and its main office is located in Franklin, Tennessee.
Share Price
$4.83
Last synced: 2026-11-09
Market Cap
$2.57B
Change (1 day)
0.21%
Change (1 year)
89.41%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Clover Health Investments, Corp. (CLOV)
Category
Healthcare
P/E ratio for Clover Health Investments, Corp. (CLOV)
P/E ratio as of November 2026 TTM: -110.12
According to Clover Health Investments, Corp.'s latest financial reports and stock price, its current price-to-earnings ratio (TTM) is -110.12. At the end of 2025 the company had a P/E ratio of -13.82.
P/E ratio history for Clover Health Investments, Corp. from 2018 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | -110.12 | 696.84% |
| 2025 | -13.82 | -61.48% |
| 2024 | -35.89 | 1,567.95% |
| 2023 | -2.15 | 65.06% |
| 2022 | -1.30 | -56.26% |
| 2021 | -2.98 | -94.01% |
| 2020 | -49.73 | 338.46% |
| 2019 | -11.34 | 434.42% |
| 2018 | -2.12 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 23.23 | -121.09% |
US
|
|
| 23.56 | -121.40% |
US
|
|
| 17.89 | -116.25% |
US
|
|
| 12.30 | -111.17% |
US
|
|
| 38.92 | -135.34% |
US
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.
Questions about Clover Health Investments, Corp.'s P/E ratio
What is Clover Health Investments, Corp.'s P/E ratio?
Clover Health Investments, Corp.'s P/E ratio is -110.12, as of Nov 2026.
What was Clover Health Investments, Corp.'s P/E ratio in 2025?
In 2025, Clover Health Investments, Corp.'s P/E ratio was -13.82, compared with -35.89 in 2024.
How has Clover Health Investments, Corp.'s P/E ratio changed since 2020?
From 2020 to 2025, Clover Health Investments, Corp.'s P/E ratio was highest in 2022 (-1.30) and lowest in 2020 (-49.73).
How does Clover Health Investments, Corp.'s P/E ratio compare with similar companies?
Clover Health Investments, Corp.'s P/E ratio (-110.12) is lower than that of all 5 similar companies listed above. The highest among them is Humana Inc., with 38.92.